Cerenome, Inc.(CNSY)

Medical - Pharmaceuticals · Houston, TX

$1.560.00 (0.00%)

Delayed quote: Oct 6, 2026, 9:30 AM EDT

EV/EBITDA Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBITDA ratio is N/A as of 2026-10-06T13:31:04.431Z.

Stored calculation inputs

Calculation as of: 2026-10-06T13:31:04.431Z.

Quote observation: 2026-10-06T13:30:00.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 10,737,651
Total debt · period ending 2026-06-30: 44,000
Cash · period ending 2026-06-30: 2,366,000
TTM operating EBITDA · period ending 2026-06-30: -25,997,000

FMP input reference: 7e5dd7cae71be814523bfc9444594aa14e5919ebae0d9bfc7936539f469f7652

EV/Sales|P/E Ratio|EBITDA|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

CNSY EV/EBITDA Ratio Metrics

EV/EBITDA RATIO

N/A

CNSY Competitors' EV/EBITDA Ratio

CNSY

Cerenome, Inc.

Current

Market Cap

$10.74M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BFRG

Bullfrog AI Holdings, Inc. Common Stock

vs CNSY

Market Cap

$10.68M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

LFWD

Lifeward Ltd.

vs CNSY

Market Cap

$10.73M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BIVI

BioVie Inc.

vs CNSY

Market Cap

$11.09M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

CABR

Caring Brands, Inc.

vs CNSY

Market Cap

$10.09M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

KPRX

Kiora Pharmaceuticals, Inc.

vs CNSY

Market Cap

$11.21M

EV/EBITDA Ratio

N/A

TTM Avg

12.81x

3Y Avg

12.81x

5Y Avg

12.81x

GDTC

CytoMed Therapeutics Limited

vs CNSY

Market Cap

$11.24M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

BFRI

Biofrontera Inc.

vs CNSY

Market Cap

$11.27M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ADIL

Adial Pharmaceuticals, Inc.

vs CNSY

Market Cap

$11.50M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

AIMD

Ainos, Inc.

vs CNSY

Market Cap

$9.94M

EV/EBITDA Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBITDA RATIO	TTM	3Y	5Y
Cerenome, Inc. (CNSY)	$10.74M	N/A	N/A	N/A	N/A
Bullfrog AI Holdings, Inc. Common Stock (BFRG)vs ›	$10.68M	N/A	N/A	N/A	N/A
Lifeward Ltd. (LFWD)vs ›	$10.73M	N/A	N/A	N/A	N/A
BioVie Inc. (BIVI)vs ›	$11.09M	N/A	N/A	N/A	N/A
Caring Brands, Inc. (CABR)vs ›	$10.09M	N/A	N/A	N/A	N/A
Kiora Pharmaceuticals, Inc. (KPRX)vs ›	$11.21M	N/A	12.81x	12.81x	12.81x
CytoMed Therapeutics Limited (GDTC)vs ›	$11.24M	N/A	N/A	N/A	N/A
Biofrontera Inc. (BFRI)vs ›	$11.27M	N/A	N/A	N/A	N/A
Adial Pharmaceuticals, Inc. (ADIL)vs ›	$11.50M	N/A	N/A	N/A	N/A
Ainos, Inc. (AIMD)vs ›	$9.94M	N/A	N/A	N/A	N/A

EV/EBITDA Ratio Formula & Definition

EV/EBITDA = Enterprise Value / EBITDA (TTM)

Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

Related Metrics

EV/Sales P/E Ratio EBITDA All Metrics